Background: Papillary thyroid cancer (PTC) is one of the most common cancers worldwide and is considered to be the most common endocrinal malignancy with a higher increase in its incidence every year. This rapid continuous increase in the incidence of thyroid cancer is suggested to be as a result of many factors as the newly developed and used radiological studies which can detect subclinical cases not discovered by physical examination. Aim of the work: This study aims to evaluate the relation of level of serum leptin in papillary thyroid carcinoma and its variability to patients and tumor characteristics. Patients and methods: In this study we measured the level of serum leptin in 20 cases of papillary thyroid carcinoma and in 20 patients with simple nodular goiter as a control group and correlated its levels with the patient characteristics as age, sex and BMI as well as the tumor characteristics and aggressiveness like tumor type, tumor size, lymph node (LN) metastasis and extrathyroidal extension. Results: We found that the levels of serum leptin were markedly higher in the group with PTC more than the control group. There was no significant difference of serum leptin among the different pathological subtypes of PTC and the correlation between serum leptin and infiltration of the surroundings was significant. Moreover, increased levels of serum leptin were associated with a larger tumor size. These results are consistent with many studies concerned with the same issue despite being conflicting with some of other studies. Conclusion: Serum leptin was found to have a strong association with PTC regarding the increased incidence and the aggressive behavior so it may be used in the diagnosis of PTC and prediction of the prognosis.
Abostate, A., Elmaraghy, A., Farahat, M., & Fadl, E. (2022). Serum Leptin as a Diagnostic Indicator for Papillary Thyroid Carcinoma. Ain Shams Journal of Surgery, 15(1), 70-79. doi: 10.21608/asjs.2022.228490
MLA
Ahmed Mostafa Hassanein Ibrahim Abostate; Abd-Elrahman Mohmmed Elmaraghy; Mahmoud Saad Farahat; Ehab Mohmmed Ali Fadl. "Serum Leptin as a Diagnostic Indicator for Papillary Thyroid Carcinoma". Ain Shams Journal of Surgery, 15, 1, 2022, 70-79. doi: 10.21608/asjs.2022.228490
HARVARD
Abostate, A., Elmaraghy, A., Farahat, M., Fadl, E. (2022). 'Serum Leptin as a Diagnostic Indicator for Papillary Thyroid Carcinoma', Ain Shams Journal of Surgery, 15(1), pp. 70-79. doi: 10.21608/asjs.2022.228490
VANCOUVER
Abostate, A., Elmaraghy, A., Farahat, M., Fadl, E. Serum Leptin as a Diagnostic Indicator for Papillary Thyroid Carcinoma. Ain Shams Journal of Surgery, 2022; 15(1): 70-79. doi: 10.21608/asjs.2022.228490
)
View on SCiNiTO